• EN
    • SV
  • About Us
    • Our History
    • Our Strategy
    • Vision, Mission, Values
  • Auditors
  • Board of Directors
  • Home
  • Investor Relations
    • Analyst Coverage
    • Annual & Quarterly Reports
    • Audit Committee
    • Board Committees
    • Event Details
    • Events and Presentations
    • Executive Team
    • FAQs
    • Financial Calendar
    • Governance Documents
    • Old prospectus
    • Ownership Structure
    • Prospectus
    • Prospectus Terms
    • Remuneration Committee
    • Share Information
    • Shareholder Meetings
    • Single Corporate Presentation
  • Join Us
    • Current Openings
    • Working with Us
  • Newsroom
    • Media Kit
    • Press Release Sign Up
    • Press Releases
    • Saniona Logo
    • Single Press Release
    • Voices
  • Nomination Committee
  • Our Pipeline
    • Development Process
    • Kv7
    • SAN2219
    • SAN2465
    • SAN2668
    • SAN903
    • Tesofensine
    • Tesomet
  • Our Science
    • Discovery Process
    • Ion Channels
    • Partnerships & Spinouts
    • Publications/Presentations
  • Patients & Caregivers
    • Epilepsy
    • Hypothalamic Obesity
    • Prader-Willi Syndrome
    • Rare Diseases
  • Privacy Policy
  • Remuneration Incentive Programs
  • BioStock
Saniona
  • EN
  • SV
INVESTORS

Annual &
Quarterly Reports

Saniona Icon blue
  • Overview
  • The Share
    • Share Information
    • Ownership Structure
  • Financial Calendar
  • Reports & Fillings
    • Annual & Quarterly Reports
    • Prospectus
    • Old prospectus
  • Analysts
  • Events and Presentations
  • FAQs
  • Corporate governance
    • Executive Team
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Shareholder Meetings
    • Nomination Committee
    • Auditors
    • Remuneration Incentive Programs

ABOUT US

Vision, mission, values

Our strategy

Executive team

Board of directors

Our history

OUR SCIENCE

Ion channels

Publications / presentations

Partnerships & spinouts

The discovery process

OUR PIPELINE

Tesofensine

Tesomet

SAN903

SAN2219

SAN2465

SAN2668

The development process

PATIENTS & CAREGIVERS

Hypothalamic obesity

Prader-Willi syndrome

Epilepsy

Rare diseases

INVESTORS

The share

Financial calendar

Financial reports and filings

Analyst coverage

Events and presentations

FAQs

Corporate Governance

NEWSROOM

Press releases

Voices

Media kit

 

JOIN US

Working with us

Current Openings

Saniona
DENMARK

Murervangen 42
DK-2600 Glostrup
Denmark
+45 7070 5225
saniona@saniona.com

CONNECT 
  • Follow
  • Follow
  • Follow

© 2026 Saniona. All rights reserved.

Privacy Policy